A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure-function relationships

dc.contributor.authorStavrakoudis, A.en
dc.contributor.authorBizos, G.en
dc.contributor.authorEleftheriadis, D.en
dc.contributor.authorKouki, A.en
dc.contributor.authorPanou-Pomonis, E.en
dc.contributor.authorSakarellos-Daitsiotis, M.en
dc.contributor.authorSakarellos, C.en
dc.contributor.authorTsoukatos, D.en
dc.contributor.authorTsikaris, V.en
dc.date.accessioned2015-11-24T16:40:26Z
dc.date.available2015-11-24T16:40:26Z
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/8277
dc.rightsDefault Licence-
dc.subjectCyclic non-RGD containing analoguesen
dc.subjectcystine non-RGD analoguesen
dc.subjectplatelet aggregation inhibitorsen
dc.subjectcyclization on solid supporten
dc.subjectdisulfide bond formationen
dc.titleA three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure-function relationshipsen
heal.abstractAntagonists of fibrinogen at the GPIIb/IIIa receptor, which is the most abundant membrane protein on the platelet surface, are under active investigation as potential antithrombotics. The critical interaction between GPIIb/IIIa and fibrinogen can be inhibited by either linear or cyclic RGDS-containing peptides, which have been proved as lead compounds in the design of platelet aggregation inhibitors. In this study we present the design and construction of a new class of cyclic (S,S) non-RGD containing peptide sequences, using two Cys as a structural scaffold for the development of antiaggregatory agents. The (S,S)-CDC- sequence was incorporated as a conformational constraint, in molecules bearing at least one positive charge with the general formula (S,S)XCDCZ, where X = Ac-Arg, Pro-Arg, Pro-Ser-Lys, and Pro-Ser-Arg, and Z = -NH2 and Arg-NH2. Investigation of the structure-function relationships was performed on the basis of (a) the local conformation induced by the (S,S)-CDC motif, (b) the distance of the positively (R-Cζ or K-Nζ) and negatively (D-Cγ) charged centers, (c) the presence of a second positive or negative charge on the molecule, and (d) the orientation of the basic and acidic side chains defined by the pseudo dihedral angle (Pdo), which is formed by the R-Cζ, R-Cα, D-Cα, and D-Cγ atoms in the case of (S,S)-RCDC and by the K-Nζ, K-Cα, D-Cα, and D-Cγ atoms in the case of (S,S)-KCDC.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1002/1097-0282(2000)56:1<20::AID-BIP1039>3.0.CO;2-K-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/doi/10.1002/1097-0282%282000%2956:1%3C20::AID-BIP1039%3E3.0.CO;2-K/abstract-
heal.journalNameBiopolymersen
heal.journalTypepeer reviewed-
heal.languageen-
heal.publicationDate2001-
heal.publisherWileyen
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: